Anti-angiogenic Potential of Tunicamycin is NOT Reversible by Vascular Endothelial Growth Factor VEGF165

被引：0
|
作者：
Banerjee, A. [1 ]
Baksi, K. [2 ]
Burgos, M. [1 ]
Banerjee, D. K. [1 ]
机构：
[1] Univ Puerto Rico, San Juan, PR 00936 USA
[2] Univ Cent Caribe, Bayamon, PR USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-angiogenic Potential of Tunicamycin is <INOT> Reversible by Vascular Endothelial Growth Factor (VEGF165
    Banerjee, Aditi
    Baksi, Krishna
    Burgos, Meriandrys
    Banerjee, Dipak K.
    FASEB JOURNAL, 2008, 22
  • [2] Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy
    Elebiyo, Tobiloba C.
    Rotimi, Damilare
    Evbuomwan, Ikponmwosa O.
    Maimako, Rotdelmwa Filibus
    Iyobhebhe, Matthew
    Ojo, Oluwafemi Adeleke
    Oluba, Olarewaju M.
    Adeyemi, Oluyomi S.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 32
  • [3] Vascular endothelial growth factor 165 (VEGF165) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165•KDR complexes
    Hamma-Kourbali, Y
    Vassy, R
    Starzec, A
    Le Meuth-Metzinger, V
    Oudar, O
    Bagheri-Yarmand, R
    Perret, G
    Crépin, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (43) : 39748 - 39754
  • [4] Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF165bIsoform in the Vitreous of Patients with Retinopathy of Prematurity
    Zhao Min
    Xie Wan-Kun
    Bai Yu-Jing
    Huang Lyu-Zhen
    Wang Bin
    Liang Jian-Hong
    Yin Hong
    Li Xiao-Xin
    Shi Xuan
    中华医学杂志英文版, 2015, 128 (18) : 2505 - 2509
  • [5] Immobilization of human vascular endothelial growth factor (VEGF165) onto biomaterials: An evaluation of the biological activity of immobilized VEGF165
    Taguchi, T
    Kishida, A
    Akashi, M
    Maruyama, I
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2000, 15 (04) : 309 - 320
  • [6] A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165)
    Koide, Hiroyuki
    Yoshimatsu, Keiichi
    Hoshino, Yu
    Lee, Shih-Hui
    Okajima, Ai
    Ariizumi, Saki
    Narita, Yudai
    Yonamine, Yusuke
    Weisman, Adam C.
    Nishimura, Yuri
    Oku, Naoto
    Miura, Yoshiko
    Shea, Kenneth J.
    NATURE CHEMISTRY, 2017, 9 (07) : 715 - 722
  • [7] A polymer nanoparticle with engineered affinity for a vascular endothelial growth factor (VEGF165)
    Koide H.
    Yoshimatsu K.
    Hoshino Y.
    Lee S.-H.
    Okajima A.
    Ariizumi S.
    Narita Y.
    Yonamine Y.
    Weisman A.C.
    Nishimura Y.
    Oku N.
    Miura Y.
    Shea K.J.
    Nature Chemistry, 2017, 9 (7) : 715 - 722
  • [8] Vascular endothelial growth factor (VEGF165) gene transfer for diabetic neuropathy
    Ropper, AH
    Pieczek, A
    Visnaw, K
    Kershen, J
    Weinberg, D
    Gorson, K
    Huang, SG
    Losordo, D
    NEUROLOGY, 2005, 64 (06) : A6 - A6
  • [9] Expression of a functional recombinant vascular endothelial growth factor 165 (VEGF165) in Arabidopsis thaliana
    Qiang, Weidong
    Feng, Xue
    Li, Yixin
    Lan, Xinxin
    Ji, Kun
    Sun, Xiaoyu
    Chen, Xi
    Li, Haiyan
    Du, Linna
    Yang, Jing
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2019, 44 (03): : 254 - 260
  • [10] Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy
    Harmey, JH
    Bouchier-Hayes, D
    BIOESSAYS, 2002, 24 (03) : 280 - 283
12345